Planning

Outpatient Dispensing Pharmacy (ODP) and associated services

  • Bristol & Weston NHS Purchasing Consortium

F01: Prior information notice (prior information only)

Notice identifier: 2021/S 000-029604

Procurement identifier (OCID): ocds-h6vhtk-02fb15

Published 29 November 2021, 5:06pm



Section one: Contracting authority

one.1) Name and addresses

Bristol & Weston NHS Purchasing Consortium

Princess Campbell Office

Bristol

BS10 5NB

Contact

BWPC Lukas Mokrolusky

Email

lukas.mokrolusky@nbt.nhs.uk

Telephone

+44 1174142681

Country

United Kingdom

NUTS code

UKK11 - Bristol, City of

Internet address(es)

Main address

http://nww.bwpc.nhs.uk/Default.htm

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=41045&B=NHSSW

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Regional or local authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Outpatient Dispensing Pharmacy (ODP) and associated services

Reference number

BWPCCL0001538

two.1.2) Main CPV code

  • 85149000 - Pharmacy services

two.1.3) Type of contract

Services

two.1.4) Short description

This notice is published for the purpose of early market engagement only and is not intended as a call for competition. Bristol & Weston NHS Purchasing Consortium (BWPC) are seeking to engage with the market to understand the suppliers who may be interested in participating in the tender.

The Trust are seeking to select a partner to provide an outsourced outpatient pharmacy dispensing service, including oral chemotherapy, antiviral treatment of hepatitis C, and compliance aids. Selected supplier will be required to provide the services in Bristol Royal Infirmary and Weston General Hospital.

The contractor will be responsible for the procurement, storage, dispensing, distribution and delivery of outpatient and day case medicines (including oral chemotherapy, antiviral treatment of hepatitis C) and provide a compliance aid service for the Trusts inpatients on discharge.

two.1.5) Estimated total value

Value excluding VAT: £10,000,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 85149000 - Pharmacy services

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

This notice is published for the purpose of early market engagement only and is not intended as a call for competition. Bristol & Weston NHS Purchasing Consortium (BWPC) are seeking to engage with the market to understand the suppliers who may be interested in participating in the tender.

The Trust are seeking to select a partner to provide an outsourced outpatient pharmacy dispensing service, including oral chemotherapy, antiviral treatment of hepatitis C, and compliance aids. Selected supplier will be required to provide the services in Bristol Royal Infirmary and Weston General Hospital.

The contractor will be responsible for the procurement, storage, dispensing, distribution and delivery of outpatient and day case medicines (including oral chemotherapy, antiviral treatment of hepatitis C) and provide a compliance aid service for the Trusts inpatients on discharge.

two.3) Estimated date of publication of contract notice

1 March 2022


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section six. Complementary information

six.3) Additional information

This notice is published for the purpose of early market engagement only. For the avoidance of doubt, this market consultation exercise implies no commercial commitment and is not a formal tender process. The information gathered will be used in the planning and conduct of any future procurement process, as well as developing the scope and specification of the requirement.

Following receipt of expressions of interest the project team will subsequently make arrangements for the next steps of the market engagement process.